You are here: Industry Insights > Takeda

News List

HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with Takeda pharmafocusasia
November 27, 2018
HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-B-cell screening and analysis, today announced...
GSK retains leading position on access to medicines list pharmatimes
November 26, 2018
GlaxoSmithKline has retained its top position among a global list of pharmaceutical companies striving to make their medicines, vaccines and diagnostics more accessible for people in low- and middle-income countries.
With EU blessing, Takeda clears final regulatory hurdle for Shire buyout—on one condition fiercepharma
November 26, 2018
Following major regulators in the U.S., China and Japan, the European Commission has given Takeda the go-ahead for its $62 billion acquisition of Shire—on one condition that Takeda is willing to fulfill.
Takeda gets European blessing for Shire acquisition pharmatimes
November 22, 2018
The European Commission has given its blessing for the proposed £46-billion acquisition of Shire by Takeda, paving the way for the deal’s completion.
Takeda must sell gastro drug to merge with Shire – EU regulators pharmaphorum
November 22, 2018
European regulators have officially rubber stamped Takeda’s $62 billion takeover of Shire, although the merged company will have to sell off a pipeline clinical trial drug for inflammatory bowel disease.
With EU blessing, Takeda clears final regulatory hurdle for Shire buyout—on one condition fiercepharma
November 22, 2018
Following major regulators in the U.S., China and Japan, the European Commission has given Takeda the go-ahead for its $62 billion acquisition of Shire—on one condition that Takeda is willing to fulfill.
Takeda sets target date to close $62B Shire deal biospectrumasia
November 19, 2018
The deal would be the largest-ever overseas acquisition by a Japanese company.Singapore Aiming to close its deal for Sh
Takeda sets target date to close $62B Shire deal biospectrum
November 14, 2018
The deal would be the largest-ever overseas acquisition by a Japanese company.
Takeda Announces Issuance of Unsecured Euro Denominated Senior Notes firstwordpharma
November 09, 2018
Osaka, Japan, November 8, 2018 --- Takeda Pharmaceutical Company Limited (TSE: 4502) (the "Company or "Takeda") announces that it is planned to launch the
Takeda Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plc firstwordpharma
October 29, 2018
Takeda Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plc

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page